DrugCite
Search

CALBLOCK

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Calblock Adverse Events Reported to the FDA Over Time

How are Calblock adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Calblock, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Calblock is flagged as the suspect drug causing the adverse event.

Most Common Calblock Adverse Events Reported to the FDA

What are the most common Calblock adverse events reported to the FDA?

Hepatic Function Abnormal
22 (2.41%)
Blood Pressure Decreased
21 (2.3%)
Liver Disorder
21 (2.3%)
Alanine Aminotransferase Increased
17 (1.86%)
Bradycardia
15 (1.64%)
Gamma-glutamyltransferase Increased
15 (1.64%)
Pyrexia
15 (1.64%)
Aspartate Aminotransferase Increase...
13 (1.43%)
Blood Alkaline Phosphatase Increase...
13 (1.43%)
Dizziness
13 (1.43%)
Loss Of Consciousness
12 (1.32%)
Show More Show More
Nausea
12 (1.32%)
Malaise
11 (1.21%)
Hypotension
10 (1.1%)
Atrial Fibrillation
9 (.99%)
Cerebral Infarction
9 (.99%)
Drug Interaction
9 (.99%)
Oedema Peripheral
9 (.99%)
Tooth Loss
9 (.99%)
Cardio-respiratory Arrest
8 (.88%)
Lacunar Infarction
8 (.88%)
Toxic Epidermal Necrolysis
8 (.88%)
Depressed Level Of Consciousness
7 (.77%)
Drug Effect Decreased
7 (.77%)
Hepatitis Acute
7 (.77%)
Intervertebral Disc Protrusion
7 (.77%)
Liver Function Test Abnormal
7 (.77%)
Overdose
7 (.77%)
Renal Failure
7 (.77%)
Sick Sinus Syndrome
7 (.77%)
Sudden Hearing Loss
7 (.77%)
White Blood Cell Count Decreased
7 (.77%)
Blood Bilirubin Increased
6 (.66%)
Blood Creatine Phosphokinase Increa...
6 (.66%)
Coma
6 (.66%)
Completed Suicide
6 (.66%)
Hyperkalaemia
6 (.66%)
Interstitial Lung Disease
6 (.66%)
Renal Impairment
6 (.66%)
Atrioventricular Block
5 (.55%)
Blood Uric Acid Increased
5 (.55%)
Chest Discomfort
5 (.55%)
Chest Pain
5 (.55%)
Cholecystitis Chronic
5 (.55%)
Cholelithiasis
5 (.55%)
Condition Aggravated
5 (.55%)
Drug Eruption
5 (.55%)
Hyperthyroidism
5 (.55%)
Intentional Overdose
5 (.55%)
Jaundice
5 (.55%)
Pneumonia
5 (.55%)
Shock
5 (.55%)
Transient Ischaemic Attack
5 (.55%)
Angina Pectoris
4 (.44%)
Anxiety
4 (.44%)
Bile Duct Stenosis
4 (.44%)
Blood Potassium Increased
4 (.44%)
Blood Pressure Diastolic Decreased
4 (.44%)
Cardiac Arrest
4 (.44%)
Cardiac Failure
4 (.44%)
Diarrhoea
4 (.44%)
Drowning
4 (.44%)
Duodenal Ulcer Haemorrhage
4 (.44%)
Dyslalia
4 (.44%)
Dyspnoea
4 (.44%)
Gallbladder Disorder
4 (.44%)
Haemangioma Of Liver
4 (.44%)
Haemodialysis
4 (.44%)
Hemiplegia
4 (.44%)
Hepatic Enzyme Increased
4 (.44%)
Hypokinesia
4 (.44%)
Incorrect Dose Administered
4 (.44%)
Jaundice Cholestatic
4 (.44%)
Leukocytoclastic Vasculitis
4 (.44%)
Lymphocyte Stimulation Test Positiv...
4 (.44%)
Multi-organ Failure
4 (.44%)
Palpitations
4 (.44%)
Pleural Effusion
4 (.44%)
Post Procedural Bile Leak
4 (.44%)
Purpura
4 (.44%)
Renal Failure Acute
4 (.44%)
Rhabdomyolysis
4 (.44%)
Sepsis
4 (.44%)
Spinal Compression Fracture
4 (.44%)
Suicide Attempt
4 (.44%)
Viith Nerve Paralysis
4 (.44%)
Acute Myocardial Infarction
3 (.33%)
Acute Respiratory Distress Syndrome
3 (.33%)
Anaemia
3 (.33%)
Aortic Dissection
3 (.33%)
Aortic Surgery
3 (.33%)
Bile Duct Obstruction
3 (.33%)
Blood Bilirubin Abnormal
3 (.33%)
Blood Potassium Decreased
3 (.33%)
Blood Pressure Inadequately Control...
3 (.33%)
Blood Urea Increased
3 (.33%)
Convulsion
3 (.33%)
Dizziness Postural
3 (.33%)
Drug Ineffective
3 (.33%)
Electrocardiogram Qt Prolonged
3 (.33%)
Enterococcal Infection
3 (.33%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Calblock, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Calblock is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Calblock

What are the most common Calblock adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Calblock, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Calblock is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Calblock According to Those Reporting Adverse Events

Why are people taking Calblock, according to those reporting adverse events to the FDA?

Hypertension
616
Drug Use For Unknown Indication
27
Product Used For Unknown Indication
20
Angina Pectoris
7
Completed Suicide
5
Essential Hypertension
4
Show More Show More
Ill-defined Disorder
4
Suicide Attempt
3
Cerebral Thrombosis
3
Renal Failure Chronic
3
Insomnia
3
Prophylaxis
3
Subarachnoid Haemorrhage
2
Hyperlipidaemia
2
Aortic Dissection
2
Cardiac Failure Chronic
2
Subdural Haematoma
2
Acute Myocardial Infarction
1
Blood Pressure Increased
1
Cardiac Failure
1
Procedural Hypertension
1
Blood Pressure Management
1

Calblock Case Reports

What Calblock safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Calblock. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Calblock.